(1)
Wu, J. .; Balu, S.; Birk Larsen, N. .; Pulleyblank, R. .; Strømkjær, L.; Quah, A.; Wiseman, M. . Cost-Per-Responder Analysis of Tralokinumab Versus Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis in the US and Canada. J of Skin 2024, 8, s317.